Cocrystal Pharma (COCP) Capital Expenditures (QoQ) (2010 - 2024)
Cocrystal Pharma (COCP) Capital Expenditures (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -86.44% |
| Jun 30, 2023 | -68.89% |
| Mar 31, 2023 | 275.00% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | -73.33% |
| Jun 30, 2021 | -40.00% |
| Mar 31, 2021 | 2,400.00% |
| Dec 31, 2020 | -94.74% |
| Sep 30, 2020 | -85.04% |
| Jun 30, 2020 | 36.56% |
| Mar 31, 2020 | 9,200.00% |
| Dec 31, 2019 | -99.13% |
| Sep 30, 2019 | 2,775.00% |
| Jun 30, 2019 | -84.00% |
| Mar 31, 2019 | 66.67% |
| Dec 31, 2018 | 87.50% |
| Jun 30, 2017 | -78.79% |
| Mar 31, 2017 | 1,550.00% |
| Dec 31, 2016 | -84.62% |
| Sep 30, 2016 | -27.78% |